Literature DB >> 29804288

CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma.

G Y López1, A Perry1, B Harding2, M Li2, M Santi2.   

Abstract

Entities:  

Year:  2018        PMID： 29804288      PMCID： PMC6258357          DOI： 10.1111/nan.12503

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN： 0305-1846            Impact factor:   8.090


× No keyword cloud information.
  14 in total

1.  BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.

Authors:  Eric H Raabe; Kah Suan Lim; Julia M Kim; Alan Meeker; Xing-Gang Mao; Guido Nikkhah; Jarek Maciaczyk; Ulf Kahlert; Deepali Jain; Eli Bar; Kenneth J Cohen; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

Authors:  Matthew Mistry; Nataliya Zhukova; Daniele Merico; Patricia Rakopoulos; Rahul Krishnatry; Mary Shago; James Stavropoulos; Noa Alon; Jason D Pole; Peter N Ray; Vilma Navickiene; Joshua Mangerel; Marc Remke; Pawel Buczkowicz; Vijay Ramaswamy; Ana Guerreiro Stucklin; Martin Li; Edwin J Young; Cindy Zhang; Pedro Castelo-Branco; Doua Bakry; Suzanne Laughlin; Adam Shlien; Jennifer Chan; Keith L Ligon; James T Rutka; Peter B Dirks; Michael D Taylor; Mark Greenberg; David Malkin; Annie Huang; Eric Bouffet; Cynthia E Hawkins; Uri Tabori
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

3.  Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas.

Authors:  Fausto J Rodriguez; M Adelita Vizcaino; Jaishri Blakeley; Christopher M Heaphy
Journal:  Acta Neuropathol       Date:  2016-09-20       Impact factor: 17.088

4.  PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.

Authors:  Erika F Rodriguez; Bernd W Scheithauer; Caterina Giannini; Amanda Rynearson; Ling Cen; Bridget Hoesley; Heather Gilmer-Flynn; Jann N Sarkaria; Sarah Jenkins; Jin Long; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2010-11-28       Impact factor: 17.088

5.  Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.

Authors:  Pankaj Pathak; Anupam Kumar; Prerana Jha; Suvendu Purkait; Mohammed Faruq; Ashish Suri; Vaishali Suri; Mehar C Sharma; Chitra Sarkar
Journal:  Brain Pathol       Date:  2017-01-06       Impact factor: 6.508

6.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

Authors:  David T W Jones; Barbara Hutter; Natalie Jäger; Andrey Korshunov; Marcel Kool; Hans-Jörg Warnatz; Thomas Zichner; Sally R Lambert; Marina Ryzhova; Dong Anh Khuong Quang; Adam M Fontebasso; Adrian M Stütz; Sonja Hutter; Marc Zuckermann; Dominik Sturm; Jan Gronych; Bärbel Lasitschka; Sabine Schmidt; Huriye Seker-Cin; Hendrik Witt; Marc Sultan; Meryem Ralser; Paul A Northcott; Volker Hovestadt; Sebastian Bender; Elke Pfaff; Sebastian Stark; Damien Faury; Jeremy Schwartzentruber; Jacek Majewski; Ursula D Weber; Marc Zapatka; Benjamin Raeder; Matthias Schlesner; Catherine L Worth; Cynthia C Bartholomae; Christof von Kalle; Charles D Imbusch; Sylwester Radomski; Chris Lawerenz; Peter van Sluis; Jan Koster; Richard Volckmann; Rogier Versteeg; Hans Lehrach; Camelia Monoranu; Beate Winkler; Andreas Unterberg; Christel Herold-Mende; Till Milde; Andreas E Kulozik; Martin Ebinger; Martin U Schuhmann; Yoon-Jae Cho; Scott L Pomeroy; Andreas von Deimling; Olaf Witt; Michael D Taylor; Stephan Wolf; Matthias A Karajannis; Charles G Eberhart; Wolfram Scheurlen; Martin Hasselblatt; Keith L Ligon; Mark W Kieran; Jan O Korbel; Marie-Laure Yaspo; Benedikt Brors; Jörg Felsberg; Guido Reifenberger; V Peter Collins; Nada Jabado; Roland Eils; Peter Lichter; Stefan M Pfister
Journal:  Nat Genet       Date:  2013-06-30       Impact factor: 38.330

7.  Anaplasia in pilocytic astrocytoma predicts aggressive behavior.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; Peter C Burger; Sarah Jenkins; Caterina Giannini
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

8.  Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.

Authors:  Yee Hui Yeo; Nicholas P Byrne; George J Counelis; Arie Perry
Journal:  Clin Neuropathol       Date:  2013 May-Jun       Impact factor: 1.368

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.

Authors:  Jinghui Zhang; Gang Wu; Claudia P Miller; Ruth G Tatevossian; James D Dalton; Bo Tang; Wilda Orisme; Chandanamali Punchihewa; Matthew Parker; Ibrahim Qaddoumi; Fredrick A Boop; Charles Lu; Cyriac Kandoth; Li Ding; Ryan Lee; Robert Huether; Xiang Chen; Erin Hedlund; Panduka Nagahawatte; Michael Rusch; Kristy Boggs; Jinjun Cheng; Jared Becksfort; Jing Ma; Guangchun Song; Yongjin Li; Lei Wei; Jianmin Wang; Sheila Shurtleff; John Easton; David Zhao; Robert S Fulton; Lucinda L Fulton; David J Dooling; Bhavin Vadodaria; Heather L Mulder; Chunlao Tang; Kerri Ochoa; Charles G Mullighan; Amar Gajjar; Richard Kriwacki; Denise Sheer; Richard J Gilbertson; Elaine R Mardis; Richard K Wilson; James R Downing; Suzanne J Baker; David W Ellison
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330
View more
  9 in total

1.  Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling.

Authors:  Ross Mangum; Jacquelyn Reuther; Kelsey C Bertrand; Raghu Chandramohan; Marcia K Kukreja; Arnold C Paulino; Donna Muzny; Jianhong Hu; Richard A Gibbs; Daniel J Curry; Fatema Malbari; Murali M Chintagumpala; Adekunle M Adesina; Kevin E Fisher; Stephen C Mack; Sharon E Plon; Angshumoy Roy; D Williams Parsons; Frank Y Lin
Journal:  JCO Precis Oncol       Date:  2021-07-28

2.  Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions.

Authors:  Jason Saliba; Alanna J Church; Shruti Rao; Arpad Danos; Larissa V Furtado; Theodore Laetsch; Liying Zhang; Valentina Nardi; Wan-Hsin Lin; Deborah I Ritter; Subha Madhavan; Marilyn M Li; Obi L Griffith; Malachi Griffith; Gordana Raca; Angshumoy Roy
Journal:  Cancer Genet       Date:  2022-03-16

3.  Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature.

Authors:  Siobhan S Pattwell; Eric Q Konnick; Yajuan J Liu; Rebecca A Yoda; Laligam N Sekhar; Patrick J Cimino
Journal:  Case Rep Pathol       Date:  2020-01-30

4.  Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.

Authors:  Lily Deland; Simon Keane; Thomas Olsson Bontell; Helene Sjögren; Henrik Fagman; Ingrid Øra; Esther De La Cuesta; Magnus Tisell; Jonas A Nilsson; Katarina Ejeskär; Magnus Sabel; Frida Abel
Journal:  Cancer Biol Ther       Date:  2021-04-05       Impact factor: 4.742

Review 5.  The oncogenic fusion landscape in pediatric CNS neoplasms.

Authors:  Mieke Roosen; Zelda Odé; Jens Bunt; Marcel Kool
Journal:  Acta Neuropathol       Date:  2022-02-15       Impact factor: 15.887

Review 6.  Simple approach for the histomolecular diagnosis of central nervous system gliomas based on 2021 World Health Organization Classification.

Authors:  Maher Kurdi; Rana H Moshref; Yousef Katib; Eyad Faizo; Ahmed A Najjar; Basem Bahakeem; Ahmed K Bamaga
Journal:  World J Clin Oncol       Date:  2022-07-24

7.  NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.

Authors:  Xiaonan Zhao; Chelsea Kotch; Elizabeth Fox; Lea F Surrey; Gerald B Wertheim; Zubair W Baloch; Fumin Lin; Vinodh Pillai; Minjie Luo; Portia A Kreiger; Jennifer E Pogoriler; Rebecca L Linn; Pierre A Russo; Mariarita Santi; Adam C Resnick; Phillip B Storm; Stephen P Hunger; Andrew J Bauer; Marilyn M Li
Journal:  JCO Precis Oncol       Date:  2021-01-14

8.  Molecular and clinicopathologic features of gliomas harboring NTRK fusions.

Authors:  Matthew Torre; Varshini Vasudevaraja; Jonathan Serrano; Michael DeLorenzo; Seth Malinowski; Anne-Florence Blandin; Melanie Pages; Azra H Ligon; Fei Dong; David M Meredith; MacLean P Nasrallah; Craig Horbinski; Sonika Dahiya; Keith L Ligon; Mariarita Santi; Shakti H Ramkissoon; Mariella G Filbin; Matija Snuderl; Sanda Alexandrescu
Journal:  Acta Neuropathol Commun       Date:  2020-07-14       Impact factor: 7.578

9.  A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.

Authors:  Siobhan S Pattwell; Sonali Arora; Patrick J Cimino; Tatsuya Ozawa; Frank Szulzewsky; Pia Hoellerbauer; Tobias Bonifert; Benjamin G Hoffstrom; Norman E Boiani; Hamid Bolouri; Colin E Correnti; Barbara Oldrini; John R Silber; Massimo Squatrito; Patrick J Paddison; Eric C Holland
Journal:  Nat Commun       Date:  2020-06-12       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.